Cited by 239Gut microbiota and healthMultiple Sclerosis Research StudiesT-cell and B-cell Immunology

Impacts of microbiome metabolites on immune regulation and autoimmunity

Open access
Haase, Stefanie, Haghikia, Aiden, Wilck, Nicola, Müller, Dominik N., Linker, Ralf A.·2018·Immunology

Abstract

A vast number of studies have demonstrated a remarkable role for the gut microbiota and their metabolites in the pathogenesis of inflammatory diseases, including multiple sclerosis (MS). Recent studies in experimental autoimmune encephalomyelitis, an animal model of MS, have revealed that modifying certain intestinal bacterial populations may influence immune cell priming in the periphery, resulting in dysregulation of immune responses and neuroinflammatory processes in the central nervous system (CNS). Conversely, some commensal bacteria and their antigenic products can protect against inflammation within the CNS. Specific components of the gut microbiome have been implicated in the production of pro-inflammatory cytokines and subsequent generation of Th17 cells. Similarly, commensal bacteria and their metabolites can also promote the generation of regulatory T-cells (Treg), contributing to immune suppression. Short-chain fatty acids may induce Treg either by G-protein-coupled receptors or inhibition of histone deacetylases. Tryptophan metabolites may suppress inflammatory responses by acting on the aryl hydrocarbon receptor in T-cells or astrocytes. Interestingly, secretion of these metabolites can be impaired by excess consumption of dietary components, such as long-chain fatty acids or salt, indicating that the diet represents an environmental factor affecting the complex crosstalk between the gut microbiota and the immune system. This review discusses new aspects of host-microbiota interaction and the immune system with a special focus on MS as a prototype T-cell-mediated autoimmune disease of the CNS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/imm.12933

Cites

116 of 116 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SCFAs promote the development of naive CD4+ T cells into regulatory T cells, induce "tolerogenic" dendritic cells in the intestinal mucosa, and limit autoimmunity.

    “SCFAs promote the development of naive CD4+ T cells into regulatory T cells (31, 32), induce “tolerogenic” dendritic cells in the intestinal mucosa (33), and limit autoimmity (34, 35).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341:569-73.
  2. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317:256-60.
  3. Cosorich I, Dalla-Costa G, Sorini C, Ferrarese R, Messina MJ, Dolpady J et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv 2017; 3:e1700492.

Cited by

Sorted by citations

Authors
Haase, S., Haghikia, A., Wilck, N., Müller, D. N., & Linker, R. A.
Affiliations
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Ruhr University Bochum (DE)
  • Max Delbrück Center (DE)
Corresponding author
Linker, Ralf A.
Venue
Immunology
Publisher
Wiley
Published
2018-04-30
Volume
154
Issue
2
Pages
230-238
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W2797170123
Cited by
239
References
116
Citations by year
2026: 15 · 2025: 30 · 2024: 23 · 2023: 26 · 2022: 39 · 2021: 39 · 2020: 37 · 2019: 18 · 2018: 11
FWCI
2.57
Type
journal article
Language
en
Open access
Locations
  • Immunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
gut microbiota metabolites, multiple sclerosis, experimental autoimmune encephalomyelitis, autoimmunity, short-chain fatty acids, tryptophan metabolites, regulatory T cells, Th17 cells, aryl hydrocarbon receptor, histone deacetylase inhibition, G protein-coupled receptors, commensal bacteria, neuroinflammation, host-microbiota interactions, dietary factors, salt intake, long-chain fatty acids
MeSH terms
Gastrointestinal Microbiome, Animals, Central Nervous System, Disease Susceptibility, Energy Metabolism, Fatty Acids, Volatile, Humans, Tryptophan, Neuroimmunomodulation, Autoimmunity, Probiotics, Autoimmune Diseases of the Nervous System, Immunomodulation, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review